Suboxone has emerged as a primary therapy for all types of opioid addiction. Having been approved in the United States in 2002, the number of physicians authorized to prescribe suboxone to patients has risen steadily year after year. The reason for this is firmly rooted in the persuasive science of opioid replacement therapy. Suboxone, and methadone, are medically-approved and in wide use today because of their proven efficacy in eliminating opioid withdrawal symptoms.
The safety and credibility of opioid replacement therapy is fortunately mainstream in today's modern health care system. Suboxone is now covered under Medicaid and many forms of private insurance. Moreover, the Division of Health and Human Services (which fund local state mental health and substance abuse services) is preparing to pay for a forthcoming generic version of suboxone.
New York has historically been a leader in opioid treatment and the implementation of medication-assisted treatments such as methadone and suboxone. New York's opioid addiction problem remains a chief concern in addiction treatment circles. Fortunately, New York physicians have embraced the medical benefits of suboxone and made it readily available to New Yorkers suffering with a debilitating opiate addictive disorder.
There is a popular phrase in addiction treatment that goes "addition is an equal opportunity disease". In other words, addiction doesn't discriminate based on age, race, gender, socioeconomic status, or religious orientation. People from all cultures, backgrounds, and walks of life have experienced an opioid addiction. Similarly, Suboxone is an equal opportunity answer to this problem, and worthy of careful consideration by those who find themselves feeling trapped and in need of help.